Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series
Juvenile dermatomyositis (JDM) has a wide spectrum of clinical presentations. In the last decade, several myositis-specific antibodies have been identified in patients with JDM and connected with specific organ involvement or specific clinical picture. It has been published that the presence of anti...
Saved in:
Main Authors: | Natasa Toplak (Author), Pallavi Pimpale Chavan (Author), Silvia Rosina (Author), Tomas Dallos (Author), Oz Rotem Semo (Author), Cassyanne L. Aguiar (Author), Raju Khubchandani (Author), Angelo Ravelli (Author), Anjali Patwardhan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atypical presentation of anti-NXP-2 positive juvenile dermatomyositis
by: Andreia Coimbra-Sousa, et al.
Published: (2023) -
Towards telehealth delivery in pediatric rheumatology practice
by: Raju Khubchandani, et al.
Published: (2023) -
Anti-NXP2 antibody positive dermatomyositis presenting as unilateral heliotrope rash
by: Zeinab F. Saleh, MD, et al.
Published: (2024) -
A case of anti‐NXP‐2‐positive dermatomyositis with generalized subcutaneous edema
by: Yukinobu Nakagawa, et al.
Published: (2020) -
Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
by: Bilginer Y, et al.
Published: (2008)